← Eichor
Study identifier: NCT07275658 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Timing and Dose of Fluid Deresuscitation in Critically Ill Patients

Condition: Fluid Overload · Critical Care, Intensive Care · Deresuscitation  ·  Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

PhaseN/A
Planned participants150
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Fluid deresuscitation is an important intervention in the Intensive Care Unit (ICU). This study aims to find (1) determinants of successful deresuscitation, (2) the optimal rate (dose) of deresuscitation based on these determinants, and (3) differences in metabolic profiles for a more personalized approach of deresuscitation. This study is a multicenter, prospective, observational cohort study in critically ill patients. This study will include ICU patients who have a clinical indication for deresuscitation as set by the treating physician. Clinical, ultrasound and laboratory values will be collected and used for analysis.

This description comes directly from the study's public registry record.

Talk to the study team

Krijna Opschoor, MD  ·  +31 (0)20 566 9111  ·  k.opschoor@amsterdamumc.nl

Santje A.S. Slot, MD  ·  s.a.s.slot@olvg.nl

Always discuss trial participation with your own doctor first.

Locations (2)

OLVGAmsterdam, NetherlandsRecruiting
Amsterdam UMCAmsterdam, NetherlandsRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07275658